questionText: To ask the Chancellor of the Exchequer, with reference to the British Business Bank's publication Small Business Equity Tracker 2024, if she will make a comparative assessment of (a) venture capital investment in the life sciences in the UK and the US and (b) the implications for companies in each jurisdiction seeking to scale-up.
answerText: The UK remains Europe’s leading destination for life sciences venture capital (VC) investment, according to the British Business Bank’s Small Business Equity Tracker 2024. The US market is larger in scale, supporting late-stage growth with deeper capital ...
heading: Life Sciences: Venture Capital